Increased expression of SAMHD1 in a subset of HIV-1 elite controllers

Eva Riveira-Muñoz, Alba Ruiz, Eduardo Pauls, Marc Permanyer, Roger Badia, Beatriz Mothe, Manel Crespo, Bonaventura Clotet, Christian Brander, Ester Ballana, José A. Esté

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)


Objectives: SAMHD1 and the CDKN1A (p21) cyclin-dependent kinase inhibitor have been postulated to mediate HIV-1 restriction in CD4+ cells. We have shown that p21 affects HIV replication through its effect on SAMHD1. Thus, we aimed at evaluating the expression of SAMHD1 and p21 in different HIV+ phenotypic groups. Patients and methods: We evaluated SAMHD1 and CDKN1A mRNA expression in CD4+ T cells from HIV+ individuals including elite controllers (n=12), individuals who control HIV without the need for antiretroviral treatment, viraemic progressors (n=10) and HIV-1 seronegative healthy donors (n=14). Immunological variables were measured by flow cytometry. Results: We show that a subset of HIV+ elite controllers with lower T cell proliferation levels (Ki67+ cells) expressed higher SAMHD1 compared with healthy donors or viraemic progressors. Conversely, there was no difference in p21 expression before or after T cell activation with a bispecific CD3/CD8 antibody. Conclusions: Our results suggest that SAMHD1 may play a role in controlling virus replication in HIV+ individuals and slow the rate of disease progression.
Original languageEnglish
Pages (from-to)3057-3060
JournalJournal of Antimicrobial Chemotherapy
Issue number11
Publication statusPublished - 1 Nov 2014


  • P21
  • Restriction factors
  • Viral control


Dive into the research topics of 'Increased expression of SAMHD1 in a subset of HIV-1 elite controllers'. Together they form a unique fingerprint.

Cite this